デフォルト表紙
市場調査レポート
商品コード
994406

ヘルスケアにおける人工知能(AI)の世界市場

Artificial Intelligence (AI) in Healthcare

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 173 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ヘルスケアにおける人工知能(AI)の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のヘルスケアにおける人工知能(AI)の市場規模は、分析期間(2020年~2027年)に39.2%のCAGRで成長する見通しで、2020年の47億米ドルから、2027年には478億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つであるソフトウェアは、分析期間中に40.5%のCAGRで成長し、339億米ドルに達すると予測されています。

当レポートは、世界のヘルスケアにおける人工知能(AI)市場について調査しており、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:37社
目次
Product Code: MCP21181

Abstract:

Global Artificial Intelligence (AI) in Healthcare Market to Reach $47.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Artificial Intelligence (AI) in Healthcare estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$47.8 Billion by 2027, growing at aCAGR of 39.2% over the period 2020-2027. Software, one of the segments analyzed in the report, is projected to record 40.5% CAGR and reach US$33.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hardware segment is readjusted to a revised 36.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 36.9% CAGR

The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2027 trailing a CAGR of 36.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 35.8% and 33.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 26.4% CAGR.

Select Competitors (Total 37 Featured) -

  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 15: World Current & Future Analysis for Pharmaceuticals & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Pharmaceuticals & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 17: World Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Natural Language Processing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World 7-Year Perspective for Natural Language Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 21: World Current & Future Analysis for Context-Aware Computing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 22: World 7-Year Perspective for Context-Aware Computing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 23: World Current & Future Analysis for Computer Vision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 24: World 7-Year Perspective for Computer Vision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 27: USA Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 28: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 29: USA Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 33: Canada Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 35: Canada Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 39: Japan Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 41: Japan Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 45: China Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 47: China Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 51: Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 53: Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • FRANCE
    • TABLE 57: France Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 59: France Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • GERMANY
    • TABLE 63: Germany Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 65: Germany Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 66: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • ITALY
    • TABLE 69: Italy Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 70: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 71: Italy Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 72: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 75: UK Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 76: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 77: UK Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 78: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 81: Rest of Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 82: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 83: Rest of Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 84: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 85: Rest of Europe Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 87: Asia-Pacific Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 88: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 89: Asia-Pacific Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 90: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 91: Asia-Pacific Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 93: Rest of World Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software and Hardware - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 94: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software and Hardware for the Years 2020 & 2027
    • TABLE 95: Rest of World Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 96: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Healthcare Payers, Other End-Uses, Hospitals & Healthcare Providers, Patients and Pharmaceuticals & Biotechnology Companies for the Years 2020 & 2027
    • TABLE 97: Rest of World Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 37